| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |